Tomohiro Fujisaki (@TomohiroFujisa2)

投稿一覧(最新100件)

RT @MasanobuIshii: Now Published! Guideline for VSA(CSA) and CMD! Worth waiting for 10 years! #INOCA #VSA #MINOCA JCS/CVIT/JCC 2023 Guid…
JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction https://t.co/QOKIUclmLv
世界で有数の心臓移植・心不全治療実績を誇り北米の拠点病院の1つであるタフツ大学病院の宮下先生と記事を書きました。Heart View 27巻1号 (2023年1月発行) アメリカにおける循環器内科集中治療医育成プログラムの現状  https://t.co/6lwLj0rZwx
Extracardiac Biopsy Sensitivity in Transthyretin Amyloidosis Cardiomyopathy Patients With Positive <sup>99 m</sup>Tc-Labeled Pyrophosphate Scintigraphy Findings https://t.co/mfkvpRDZR3
https://t.co/zytsaTqbVg The role of advance care planning and palliative care in new york city during COVID-19 pandemic https://t.co/FTEIGtdVSa

お気に入り一覧(最新100件)

Patients hospitalized with acute heart failure were getting older, but mortality and readmission rates slightly decreased during the 2010s in Japan. By Koshiro Kanaoka @koshiroook https://t.co/c0o58id9tM #circ_j #CardioTwitter https://t.co/kUszkzALE0
人工知能により算出したangioFFR(シーメンス社)の精度は、侵襲的FFRと比較して良好な結果であった By 大森 寛行 @gUPHI5nmNdxR41n https://t.co/S96Bo8OaUw #circ_j https://t.co/bozuOIYT9c
Now Published! Guideline for VSA(CSA) and CMD! Worth waiting for 10 years! #INOCA #VSA #MINOCA JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction https://t.co/5T1AHlBgUP

フォロー(646ユーザ)の投稿一覧(直近7日間)

フォロワー(612ユーザ)の投稿一覧(直近7日間)